October 4, 2016 — Federal judges have centralized dozens of Abilify lawsuits into a Multi-District Litigation (MDL No. 2734) in the Northern District of Florida under Judge M. Casey Rodgers.
According to the transfer order (PDF), there are currently 22 Abilify lawsuits pending in 12 district courts. The judges were also notified of another 20 related lawsuits in 14 districts.
Bristol-Myers Squibb and Otsuka Pharmaceuticals are accused of failing to warn about impulse-control disorders. All of the plaintiffs experienced compulsive gambling behaviors after taking Abilify. Lawyers say drug-makers should have known about the risk.
All of the parties expressed unanimous support for the Northern District of Florida, where two lawsuits are currently pending.
The MDL process has many advantages — avoiding inconsistent pretrial rulings, eliminating duplicate discovery, and conserving the resources of everyone involved. After the discovery process is complete, lawyers typically choose a few cases for “bellwether” trials and use the outcomes to negotiate settlements.
Abilify contains aripiprazole, an antipsychotic drug that treats mental illness by balancing levels of dopamine in the brain. In some cases, this over-stimulates the “reward center” in the brain and causes uncontrollable urges to gamble, eat, shop, and have sex.
Do I have an Abilify Lawsuit?
The Schmidt Firm, PLLC is currently accepting Abilify induced injury cases in all 50 states. If you or somebody you know became addicted to gambling, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.